Literature DB >> 18470711

Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.

C Cheval1, J F Timsit, M Garrouste-Orgeas, M Assicot, B De Jonghe, B Misset, C Bohuon, J Carlet.   

Abstract

OBJECTIVE: To evaluate the accuracy of procalcitonin (PCT) in predicting bacterial infection in ICU medical and surgical patients.
SETTING: A 10-bed medical surgical unit.
DESIGN: PCT, C-reactive protein (CRP), interleukin 6 (IL-6) dosages were sampled in four groups of patients: septic shock patients (SS group), shock without infection (NSS group), patients with systemic inflammatory response syndrome related to a proven bacterial infection (infect. group) and ICU patients without shock and without bacterial infection (control group).
RESULTS: Sixty patients were studied (SS group:n=16, NSS group,n=18, infect. group,n=16, control group,n=10). The PCT level was higher in patients with proven bacterial infection (72+/-153 ng/ml vs 2.9+/-10 ng/ml,p=0.0003). In patients with shock, PCT was higher when bacterial infection was diagnosed (89 ng/ml+/-154 vs 4.6 ng/ml+/-12,p=0.0004). Moreover, PCT was correlated with severity (SAPS:p=0.00005, appearance of shock:p=0.0006) and outcome (dead: 71.3 g/ml, alive: 24.0 g/ml,p=0.006). CRP was correlated with bacterial infection (p<10(-5)) but neither with SAPS nor with day 28 mortality. IL-6 was correlated with neither infection nor day 28 mortality but was correlated with SAPS. Temperature and white blood cell count were unable to distinguish shocked patients with or without infection. Finally, when CRP and PCT levels were introduced simultaneously in a stepwise logistic regression model, PCT remained the unique marker of infection in patients with shock (PCT> or =5 ng/ml, OR: 6.2, 95% CI: 1.1-37,p=0.04).
CONCLUSION: The increase of PCT is related to the appearance and severity of bacterial infection in ICU patients. Thus, PCT might be an interesting parameter for the diagnosis of bacterial infections in ICU patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 18470711     DOI: 10.1007/BF02900729

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  22 in total

1.  Interleukin-6, C-reactive protein, lactoferrin and white blood cell count in patients with S. aureus septicemia.

Authors:  B Söderquist; K G Sundqvist; I Jones; H Holmberg; T Vikerfors
Journal:  Scand J Infect Dis       Date:  1995

2.  Procalcitonin in early detection of postoperative complications.

Authors:  H B Reith; U Mittelkötter; E S Debus; C Küssner; A Thiede
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

3.  Measurement of procalcitonin levels in children with bacterial or viral meningitis.

Authors:  D Gendrel; J Raymond; M Assicot; F Moulin; J L Iniguez; P Lebon; C Bohuon
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

4.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

5.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Authors:  C J Fisher; J F Dhainaut; S M Opal; J P Pribble; R A Balk; G J Slotman; T J Iberti; E C Rackow; M J Shapiro; R L Greenman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

6.  Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock.

Authors:  S Endo; K Inada; Y Yamada; T Takakuwa; T Kasai; H Nakae; M Yoshida; M Ceska
Journal:  Crit Care Med       Date:  1994-06       Impact factor: 7.598

7.  Serious bacterial infections. C-reactive protein as a serial index of severity.

Authors:  H Peltola; M Jaakkola
Journal:  Clin Pediatr (Phila)       Date:  1988-11       Impact factor: 1.168

8.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.

Authors:  M R Pinsky; J L Vincent; J Deviere; M Alegre; R J Kahn; E Dupont
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

9.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

10.  Value of measurement of C-reactive protein in febrile patients with hematological malignancies.

Authors:  E Rintala; K Irjala; J Nikoskelainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

View more
  15 in total

Review 1.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

2.  [New Sepsis-3 definition : Do we have to treat sepsis before we can diagnose it from now on?]

Authors:  T Schmoch; M Bernhard; F Uhle; M Gründling; T Brenner; M A Weigand
Journal:  Anaesthesist       Date:  2017-08       Impact factor: 1.041

3.  [Association of inflammatory indices with the severity of urinary sepsis: analysis of 70 cases].

Authors:  Leming Tan; Cheng Yang; Xukai Yang; Yangmin Wang; Gaoping Cai; Zhigang Cao; Chuang Huang; Dongbo Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

4.  Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia.

Authors:  Nicolas Boussekey; Olivier Leroy; Serge Alfandari; Patrick Devos; Hugues Georges; Benoit Guery
Journal:  Intensive Care Med       Date:  2006-02-14       Impact factor: 17.440

5.  A composite score combining procalcitonin, C-reactive protein and temperature has a high positive predictive value for the diagnosis of intensive care-acquired infections.

Authors:  Laurent Robriquet; Caroline Séjourné; Eric Kipnis; Michele D'Herbomez; François Fourrier
Journal:  BMC Infect Dis       Date:  2013-04-02       Impact factor: 3.090

6.  Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.

Authors:  Shahin Gaïni; Ole Graesbøll Koldkjaer; Court Pedersen; Svend Stenvang Pedersen
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Diagnostic value of procalcitonin and apo-e in extrahepatic biliary atresia.

Authors:  Mandana Rafeey; Lida Saboktakin; Jamshid Shoa Hassani; Fatemeh Farahmand; Saied Aslanabadi; Amir Ghorbani-Haghjou; Sadegh Poorebrahim
Journal:  Iran J Pediatr       Date:  2014-02-18       Impact factor: 0.364

8.  Prognostic Value and Daily Trend of Interleukin-6, Neutrophil CD64 Expression, C-Reactive Protein and Lipopolysaccharide-Binding Protein in Critically Ill Patients: Reliable Predictors of Outcome or Not?

Authors:  Dragan Djordjevic; Janko Pejovic; Maja Surbatovic; Jasna Jevdjic; Sonja Radakovic; Milic Veljovic; Aneta Peric; Tamara Andjelic; Nada Popovic
Journal:  J Med Biochem       Date:  2015-09-19       Impact factor: 3.402

9.  The role of C-reactive protein as a diagnostic predictor of sepsis in a multidisciplinary Intensive Care Unit of a tertiary care center in Nepal.

Authors:  Saurabh Pradhan; Ashish Ghimire; Balkrishna Bhattarai; Bashudha Khanal; Krishna Pokharel; Madhab Lamsal; Sidhhartha Koirala
Journal:  Indian J Crit Care Med       Date:  2016-07

10.  A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.

Authors:  Shahin Gaïni; Ole G Koldkjaer; Holger J Møller; Court Pedersen; Svend S Pedersen
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.